Pfizer Independent Medical Education Grant Request for Proposals: Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate Cancer
Pfizer Inc. funds educational projects to close knowledge and skills gaps in HRRm testing for metastatic prostate cancer among multidisciplinary healthcare teams.
Funder: Pfizer Inc.
Due Dates: October 8, 2026: Submission Deadline
Funding Amounts: Total budget approx. $300,000; individual projects up to $100,000; smaller projects ($30,000–$50,000) encouraged; max project length 12 months.
Summary: Supports independent medical education projects that enhance healthcare professionals’ skills and confidence in HRRm testing for metastatic prostate cancer, emphasizing practical, multidisciplinary education.
Description
This grant from Pfizer Inc. aims to fund high-impact independent medical education (IME) initiatives that address significant knowledge, skill, and confidence gaps among healthcare professionals regarding Homologous Recombination Repair mutation (HRRm) testing in metastatic prostate cancer. The focus is on moving beyond foundational knowledge to equip multidisciplinary teams with practical skills for implementing guideline-based HRRm testing throughout the patient care pathway. Projects should emphasize comprehensive, practical educational resources, case-based learning, and frameworks that support evidence-based HRRm testing, particularly in bridging the gap between academic and community practice settings. Outcomes should include measurable improvements in learner competence, multidisciplinary collaboration, and the application of HRRm testing in real-world clinical scenarios.
